
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license a... AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0204 | 0.752878653676 | 2.7096 | 3.5 | 2.66 | 5762 | 2.80623969 | CS |
4 | -0.07 | -2.5 | 2.8 | 3.5 | 2.38 | 8663 | 2.70631276 | CS |
12 | -0.33 | -10.7843137255 | 3.06 | 3.7064 | 2.38 | 7651 | 2.93288683 | CS |
26 | -2.92 | -51.6814159292 | 5.65 | 6.4 | 2.38 | 7702 | 3.43218502 | CS |
52 | -3.485 | -56.0740144811 | 6.215 | 6.7738 | 2.38 | 7514 | 3.49334844 | CS |
156 | -3.485 | -56.0740144811 | 6.215 | 6.7738 | 2.38 | 7514 | 3.49334844 | CS |
260 | -3.485 | -56.0740144811 | 6.215 | 6.7738 | 2.38 | 7514 | 3.49334844 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約